News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Eli Lilly and Company Wins Longer Halt Of Generic Strattera Sales
August 27, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, Aug 27 (Reuters) - A federal appeals court has extended a temporary order blocking 10 companies from selling generic versions of Eli Lilly and Co's (LLY.N) Strattera attention deficit disorder drug.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Eli Lilly and Company
MORE ON THIS TOPIC
Government
Former DARPA Official Jackson Named ARPA-H Head
November 25, 2025
·
2 min read
·
Tristan Manalac
Legal
UPDATE: GSK’s Tesaro Sues AnaptysBio Over Current Jemperli Contract; Anaptys Countersues
November 21, 2025
·
3 min read
·
Tristan Manalac
FDA
Makary Eyes ‘America-First’ User Fee Structure as Renewal Negotiations Approach
November 19, 2025
·
2 min read
·
Tristan Manalac
Government
Signs of Frustration Build Between Kennedy and FDA Commissioner Makary
November 17, 2025
·
2 min read
·
Tristan Manalac
